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Background: Umbilical cord mesenchymal stem cells (UCMSCs) have a considerable advantage and potential in
treating for central nervous system diseases and have become a novel alternative treatment for spinal cord injury.
This study aims to compare the neurological function outcome of stem cell transplantation, rehabilitation therapy,
and self-healing for sequelae of spinal cord injury.
Methods: Thirty-four cases of thoracolumbar spinal cord injury were randomly divided into three groups: the stem
cell transplantation group was given CT-guided UCMSC transplantation twice; the rehabilitation group received
rehabilitation therapy; and the blank control group did not receive any specific treatment. AIS grading, ASIA scoring,
the manual muscle strength and muscle tension scale, and the Barthel index were used to evaluate the clinical
outcome. Urodynamic examination was also performed for patients in the UCMSC group and the rehabilitation
therapy group.
Results: Seven of the ten patients in the UCMSC group had significant and stable improvement in movement,
self-care ability, and muscular tension; five of the forteen patients (36%) in the rehabilitation group also had certain
improvement in these aspects. Urodynamic examination demonstrated that patients in the UCMSC group exhibited
an increase in maximum urinary flow rate and maximum bladder capacity, as well as a decrease in residue urine
volume and maximum detrusor pressure. The rehabilitation group exhibited decreased maximum bladder capacity,
but no perceptible change in maximum urinary flow rate, residue urine volume or maximum detrusor pressure.
Conclusions: UCMSC transplantation can effectively improve neurological functional recovery after spinal cord
injury, and its efficacy is superior to that of rehabilitation therapy and self-healing.
Trial registration: The present clinical study was registered at chictr.org (registration number: NCT01393977).
Keywords: Umbilical cord mesenchymal stem cell, Spinal cord injury, Transplantation, Urodynamic examinationBackground
Thoracolumbar spinal cord injury has a relatively high rate
of incidence, and reports have indicated that cervical,
thoracic and lumbar spine injuries account for 4.9%,
28.0%, and 65.9% of total thoracolumbar spinal injuries,
respectively [1]. Thoracolumbar spinal cord injuries are
manifested primarily by paralysis of the lower limbs, bowel* Correspondence: doctoran2010@hotmail.com
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formed in acute phases with ganglioside (GM-1),
mouse nerve growth factor (NGF), etc. [4,5]. Conven-
tional rehabilitation therapy was the preferred treat-
ment for convalescence and sequelae-phase spinal cord
injury. Occupational therapy, limb massage, functional
breathing and defecation training, etc. can to some extent
delay disuse muscle atrophy and retain a portion of limb
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UCMSC group 35.30 ± 8.23 21.40 ± 12.96 [12,50] A
Rehabilitation group 36.64 ± 9.90 18.57 ± 11.35 [12,55] A
Blank control group 32.40 ± 7.72 30.70 ± 19.99 [12,52] A
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spinal cord injury may impede neural regeneration.
Tthrombosis, rupture and occlusion of blood vessels
supporting the spinal cord may lead to ischemia and
hypoxia; micro-environment changes at the damage site
can cause massive inflammatory cell infiltration and in-
flammatory cytokine release that also impede neural re-
generation. Bleeding, inflammatory factor secretion, and
arachnoid rupture after injury may result in disorders in
local cerebrospinal fluid circulation that lead to aggrega-
tion of toxic substances and blockage of neurotrophic
factors transporting to the site of injury. A local glial
scar may form after injury, which impedes axon growth
[8-11]. These factors represent the obstacles in neuro-
functional recovery that cannot be overcome by conven-
tional rehabilitation therapy.
In recent years, stem cell transplantation has become a
novel alternative treatment for sequelae of spinal cord
injury, and a large number of reports have covered this
topic. In a canine model, neural stem cells transplanted
at the site of a hemitransected spinal cord can differenti-
ate into mature neurons and oligodendrocytes, promot-
ing recovery of the spinal cord function [12]. Canine
bone marrow mesenchymal stem cells transplanted into
the site of spinal cord injury promoted nerve cell regen-
eration and reduced fibrosis, thereby contributing to the
recovery of neural function [13]. Adipose tissue-derived
mesenchymal stem cells (ADMSCs) can be used in the
treatment for sequelae of spinal cord injury more than 1
year after initial injury, and is proved to be safe in the
follow-up [14]. Transplantation of human umbilical cord
blood-derived mesenchymal cells into rats at the hemi-
transected spinal cord showed significant improvement
in electrophysiological examination [15]. In the treat-
ment of acute spinal cord injury, human umbilical cord
mesenchymal cells transplanted into rats promoted the
recovery of spinal cord morphology and function [16].
Umbilical cord mesenchymal stem cell (UCMSCs) can
differentiate into neurons, glial cells and vascular endo-
thelial cells under specific inducing conditions. UCMSCs
can also generate cytokines and neurotrophic factors
including vascular endothelial growth factor (VEGF),
glial cell line-derived neurotrophic factor (GDNF) and
brain derived neurotrophic factor (BDNF) that support
neural regeneration, promote axon growth, and acti-
vate damaged neurons. In addition, UCMSCs can also
inhibit glial scar formation, alleviate scar obstructions,
and activate endogenous neural stem cells [17-21].
This type of stem cell is widely available without any
ethical conflicts or damage to the cell donor and thus
has great advantage and potential in treatment for cen-
tral nervous system diseases.
This study used umbilical cord mesenchymal stem
cells for transplantation and compared neurofunctionaloutcomes of patients suffering sequelae of thoracolum-
bar spinal cord injury that were treated with stem cell
transplantation, rehabilitation training, or no treatment.
Methods
Study subjects
As shown in Table 1, 34 cases of thoracolumbar spinal
cord injury that were graded ‘A’ by the AIS grading sys-
tem were randomly divided into 3 groups: the stem cell
transplantation group, the rehabilitation therapy group,
and the blank control group. The 34 patients were diag-
nosed by magnetic resonance (MR) and computed tom-
ography (CT) examination 12–72 (23.19 ± 15.67) months
post-injury, were aged 19–57 (35.25 ± 8.96) years and
were injured at a point between the 10th thoracic verte-
bra (T10) to the 1st lumbar vertebra (L1). The injuries
were caused by a traffic accident in 16 cases, falling from
high place in 7 cases, heavy pound in 5 cases, and a
sword wound in 6 cases. Excluding criteria were as fol-
lows: 1. anemia, hypoalbuminemia, or diabetes; 2. syr-
ingomyelia, spinal cord compression, or tethered cord;
3. pressure ulcers or infectious diseases (such as pneu-
monia, bacteremia, sepsis, etc.); 4. severe heart, pulmon-
ary dysfunction; 5. highly allergic constitution; and 6.
renal pelvis and ureter hydronephrosis or urinary tract
stones that lead to renal insufficiency. The three groups
showed no significant difference in age or post-injury
age. Patients of the stem cell transplantation group all
signed consent forms for stem cell therapy. The entire
treatment protocol is approved by the Ethics Committee
of the General Hospital of Chinese People's Armed Po-
lice Forces.
Cell preparation
Cell Preparation were performed as previously described
[22]. Briefly, umbilical cord tissue was obtained from
full-term healthy newborns after their parents signed the
informed consent. The tissue was disinfected in 75% al-
cohol for 30 seconds, had the Wharton's jelly peeled off,
and was then cut into 0.5 cm3 pieces. The sample was
centrifuged at 250xg for 5 minutes and was cultured
with α-MEM medium that contained 10% fetal bovine
serum at 37°C in an incubator containing 5% CO2. The
medium was changed every three days. Approximately
10 days later, the umbilical cord tissue was removed, and
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tured to 80% confluence and were passaged after diges-
tion with 0.25% trypsin. Cells of the 6-8th passage were
identified by flow cytometry to confirm their purity and
to exclude bacteria, fungi and mycoplasma conta-
mination, and were then used for transplantation. Fifty
microliterss of cell suspension (cell concentration was
4 × 105 cells/μl) was injected into two sites of the spinal
cord, 25 μl at each site. The transplantation was re-
peated once. In total, 4 × 107 cells were transplanted.
Identification of UCMSCs
The flow cytometry was performed to detect the cell
purity. Levels of CD105, CD90, CD73 and CD44 were all
higher than 95%, whereas CD19, CD45, CD11b or CD34
were all lower than 5% (Figure 1). The cells were then
used for transplantation.Figure 1 Flow cytometry analysis for UCMSCs. The levels of CD105, CD
CD11b or CD34 were lower than 5%.Therapeutic schedule
The schedule for stem cell transplantation group was as
follows: patients first underwent neurological assessment
and urodynamic examination and then received CT-
guided spinal cord stem cell transplantation twice. The
two transplantations were separated by 10 days. The pa-
tients received no further treatment of any type after
transplantation and underwent neurological assessment
and urodynamic examination again 6 months later.
Methods for CT-guided spinal cord stem cell trans-
plantation were performed as previously described [22].
Briefly, the transplantation was performed in the CT
room and a disposable 9# lumbar puncture needle was
used. The patient lay in the prone position on the CT
examination bed, according to an MR image and neuro-
logical examination. A puncture was made at the junc-
tion of the normal and injured spinal cord where stem90, CD73 and CD44 were higher than 95%, whereas CD19, CD45,
Figure 3 An axial (transverse) image: the needle reached the
spinal cord. The red line 1 indicates the spinal cord; the red line 2
indicates the needle; the red line 3 indicates the subarachnoid.
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process, depth and direction of the puncture needle was
adjusted according to the images of multiple CT scan
and 3-dimensional reconstructions. When the needle
penetrated into the subarachnoid space, iodixanol was
used as a contrast medium to show the spinal cord
(Figures 2 and 3). The needle was slowly punctured into
the spinal cord, and a total of 2 × 107 cells were injected
in two aliquots. The two injections were spaced by 3
min, and the needle remained in place for another 3 min
before being slowly withdrawn.
The treatment schedule for the rehabilitation therapy
group was as follows: patients first underwent neuro-
logical assessment and urodynamic examination and
then received rehabilitation therapy. The rehabilitation
therapy included functional recovery training and urin-
ary retention training. The treatment course lasted for
90 days with no further treatment of any type, and the
patients were examined again 6 months later.
The treatment schedule for the blank control group
was as follows: patients were left at home for self-
healing with no specific treatment.
Efficacy evaluation
All of the neurofunctional assessments were performed
by a single rehabilitation assessor who had no knowledge
of the grouping or treatment. Muscle strength, muscle
tension, sensation of the paralyzed limbs, and self-careFigure 2 A sagittal image: the needle reached the spinal cord.
The red line 1 indicates the subarachnoid; the red line 2 indicates
the spinal cord; the red line 3 indicates the needle.ability were evaluated according to the ASIA score, the
manual muscle strength and muscle tension scale, and
the Barthel Index. Patients of the stem cell group, re-
habilitation group, and blank control group were exam-
ined before treatment and 6 months after treatment.
Urodynamic examination
Bladder pressure, bladder volume, voiding pressure, and
flow rate were tested using the Medtronic urodynamic
system. Maximum urinary flow rate, maximum bladder
capacity, residual urine volume, and maximum detrusor
pressure were determined. The stem cell transplantation
group and rehabilitation therapy group were examined
prior to and 6 months post treatment.
Statistical analysis
All of the data obtained were processed by SPSS13 software
and are shown as the means ± standard deviations. Each
neurofunctional score before and after treatment was




After stem cell transplantation, the patients showed im-
provement in sensation; the score was raised from
146.60 ± 22.35 to 148.30 ± 20.99, but it was not statisti-
cally significant (Table 2, P > 0.05). Motion, muscle ten-
sion, and self-care ability significantly improved; that is,
the strength of waist, abdomen, and lower limbs in-
creased, excessive muscle tension decreased, and self-
care ability was strengthened (Table 2, P < 0.05). The

























P 0.052 0.012 0.007 0.001
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tion, motion, and self-care ability, from 147.57 ± 29.63,
55.00 ± 6.66, and 37.86 ± 17.94 before treatment to
148.12 ± 23.33, 56.64 ± 9.09, and 38.21 ± 17.72 after
treatment, respectively. However, the differences were not
statistically significant (Table 3, P > 0.05). The muscle
tension of this group increased from 14.29 ± 11.74 be-
fore treatment to 16.00 ± 13.34 after treatment, but the
difference was also not statistically significant (Table 3,
P > 0.05). The blank control group showed no signi-
ficant changes in sensation, motion, muscle tension, or
self-care ability (Table 4, P > 0.05).
Urodynamic analysis
All of the patients of the stem cell transplantation group
underwent urodynamic examination before and after treat-
ment. Six months after stem cell treatment, maximum
bladder capacity significantly increased and maximum de-
trusor pressure significantly decreased compared with those
variables before treatment (Table 5, P < 0.05). Although the
maximum urinary flow rate seemed increase and the re-
sidual urine volume seemed to decrease, the differences
were not statistically significant (Table 5, P > 0.05). Ten of
the 14 patients of the rehabilitation group were subjected
to urodynamic examination before and after rehabilitation
therapy. All of the urodynamic indicators showed a ten-
dency of deterioration, but none were statistically signifi-
cant except for maximum bladder capacity (Table 6). Since
the blank control group was not treated at all, urodynamic
examination was not performed for this group to avoid
complications related to this test (infection, urine leakage,
hematuria, etc.).
Radiation safety
CT-guided spinal cord stem cell transplantation was per-













P - 0.140criteria for computed tomography (European Community
working paper-EUR16262.1997.4) and the European Radio-
logical Protection Association. No serious radiation-related
adverse events occurred during treatment or follow-up.
Adverse reactions
Only one patient in the stem cell treatment group pre-
sented radiating neuralgia after surgery (10%), and this
was alleviated spontaneously in 24 hr. The reason is that
the injured spinal nerve formed the adhesions at differ-
ent degrees after spinal cord injury. When the needle
was slowly punctured into spinal cord, it directly
simulted the nerve roots and caused the radiating neur-
algia. No adverse effects were observed in other groups.
Discussion
Through scaled ratings and urodynamic examinations,
this study proved that transplantation of UCMSCs has
advantages in neurofunctional recovery in comparison
with rehabilitation therapy and self-healing alone. The
stem cell transplantation group improved significantly in
motor function (P = 0.012); that is, the muscle strength
of the waist, abdomen, and lower limbs increased. Seven
of the 10 patients had their muscle strength increased
from level 0 to level 1 or 2 (data not shown), and motor
function of the paralyzed limbs improved as muscle
strength increased. The rehabilitation group and blank
control group also showed some improvements but the
difference was not statistically significant (P > 0.05).
Regarding muscle tension, excessive muscle tension signifi-
cantly decreased (P = 0.007) after stem cell transplantation.
Eight patients showed excessive muscle tension before
treatment, and 7 of them (87.5%) had their muscle tension
decreased (data not shown); the rehabilitation group and
blank control group showed no significant improvements
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ities such as bed-chair transfer, bowel and urinary retention,
and ground movements, which are related to a decrease in
excessive muscle tension and an improvement in move-
ment ability of the paralyzed limbs. The rehabilitation
group showed some improvements but the differences were
not statistically significant (P > 0.05). The self-care ability of
the blank control group decreased (P > 0.05), most likely
representing functional decline of the limbs due to lack of
treatment and use. All of the three groups improved in sen-
sation, and the outcome of the stem cell transplantation
group was superior to that of the other two groups, but the
difference was not statistically significant. In addition, we
observed that patients had their lower limb blood circula-
tion improved after stem cell transplantation, which was
manifested by an increase in skin temperature, change of
skin color from pale to ruddy, a decrease in skin pigmenta-
tion, etc., but because no objective evaluation of these im-
provements is available, that was not quantified.
In summary, the efficacy of stem cell transplantation is
superior to that of rehabilitation therapy and self-healing
in the improvement of motor ability, muscle tension,
self-care ability, etc. The rehabilitation group and blank
control group showed difference primarily in self-care abil-
ity (the Barthel index of the rehabilitation group rose from
37.86 ± 17.94 to 38.21 ± 17.72, whereas that of the blank
control group dropped from 35.00 ± 8.17 to 33.16 ± 9.68),
and the patients of the rehabilitation group were likely
taught some tricks in controlling their limbs and sphincters
through bodily function recovery and urinary retention
training and thus had an advantage over the blank control
group. The blank control group showed no significant dif-
ferences in sensation, movement, muscle tension, or self-
















P 0.515 0.009that spinal cord function tends to be stable one year after
injury [23], which is also why we chose patients who had
been injured 1 year prior to the beginning of the study.
In the urodynamic examination, urination disorder
due to thoracolumbar spinal cord injury is usually mani-
fested with detrusor hyperreflexia, flabby bladder neck
and proximal urethra, reduced bladder capacity, low
compliance of the bladder, residue urine of varying
amount and loss of coordination in both the detrusor
and sphincter that result in low urine flow rate [24-26].
Urodynamic examination shows that maximum bladder
capacity decreases, residue urine volume emerges or in-
creases, maximum detrusor pressure increases, and
maximum urinary flow rate decreases. After stem cell
transplantation, urodynamic indicators showed some im-
provements: an increase in maximum bladder capacity
and a decrease in maximum detrusor pressure were
most significant (P = 0.09 and P = 0.023, respectively),
maximum urinary flow rate also showed increasing ten-
dency and residual urine volume decreased, indicating
improvements in both urine storage and voiding func-
tion of the bladder. After stem cell treatment, changes in
clinical manifestations of the patients were that urine
could be sensed and retained for a period of time, void-
ing was smooth, voiding frequency decreased, and the
amount of urine of each time increased and voiding time
shortened. Only 2 of the 10 patients had urinary infection
or urinary calculus (2/10, 20%). Patients of the rehabili-
tation group showed a significant decrease in maximum
bladder capacity (P = 0.043). They also showed decreas-
ing tendencies of maximum urinary flow rate, an in-
crease in residual urine volume, and an increase in
maximum detrusor pressure, but these changes were





























[min,max] [min,max] [min,max] [min,max]
Before transplantation 3.7 ± 5.12 433. 00 ± 41.17 54.00 ± 57.71 17.60 ± 39.35
[0,10.3] [400,500] [0,150] [0,88]
After transplantation 2.62 ± 3.90 397.00 ± 63.06 186.00 ± 115.02 19.00 ± 42.49
[0,8.7] [330,500] [30,350] [0,95]
P 0.222 0.043 0.082 0.374
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frequent urination, and reduced urine volume of each
voiding, indicating an abnormality in urine storage and
the voiding function of the bladder. Nine of the 14 pa-
tients (64%) relied on daily intermittent catheterization
and assisted urination through pressure on the lower
abdomen. Due to repeated catheterization and excessive
external force on squeezing the bladder, 8 of the 14 pa-
tients (57%) showed varying degrees of hematuria, urinary
tract infections and urinary calculus, hydronephrosis in
the renal pelvis and ureter, renal abnormalities, etc. The
stem cell transplantation group showed significant im-
provements in voiding function compared with the re-
habilitation group. They could better sense, retain, and
void urine, and urinary tract infections and urinary calcu-
lus consequently decreased.
Conclusions
This study demonstrated that umbilical cord mesen-
chymal stem cell transplantation is effective in the
treatment for sequelae of thoracolumbar spinal cord
injury. This method can alleviate lower limb muscle
tension, increase limb strength, and improve urinating
function. The method’s efficacy is more significant in
comparison with rehabilitation therapy, and no adverse
effects were found.
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